Oncology & Hematology Medical Billing Services
Oncology billing is high value and high scrutiny. Drug authorization, units, wastage, and payer policies can change the outcome of a single claim by thousands of dollars, which is why this work needs disciplined tracking.
Reading time about 4 minutes · Reviewed by the Guardian billing team
Drug claims need a process, not a person
Authorization, billing units, wastage documentation, and payer-specific drug policies all have to line up before a claim is submitted. When one piece is missing, the denial is large and the appeal is slow.
We build a pre-submission checklist for drug claims and track authorization status by patient and regimen, so nothing is discovered after administration.
- Prior authorization and regimen-specific payer policies
- Unit calculation and wastage documentation
- J-code selection and supporting records
- Clinical trial and off-label coverage considerations
Supporting the whole care team
Oncology practices coordinate physicians, infusion staff, pharmacy, and financial counselors. Billing has to fit into that flow rather than interrupt it.
Reporting focuses on what the team can act on: authorizations expiring, claims awaiting records, and denials by payer policy.
Measures worth reviewing
Numbers only help if they are defined the same way each month. These are the four we would look at first for a oncology & hematology practice.
- Drug claim denial rate by payer and regimen
- Authorization lead time before administration
- Wastage and unit documentation accuracy
- Days in A/R for drug claims
Frequently asked questions
Authorization coordination can be part of the agreed scope, with status tracked per patient and regimen so expirations are visible in advance.
Build a plan for your practice
Request an introductory review to identify what information is needed, what the current workflow does well, and what may be worth investigating first.